Get Live Data

We value your feedback, take our 2025 surveyhere

Less Ads, More Data, More Tools Register for FREE

Sponsored Content
Don't want ads? Click here

Sponsored Content
Don't want ads? Click here

Latest Share Chat

Sponsored Content

IQ-AI Professional Share News (IQAI)

IQ-AI Information

Add IQAI to Timeline
Add IQAI to Watchlist
Add IQAI to Alert
Buy IQAI Shares

Share Price Information for IQ-AI (IQAI)

London Stock Exchange

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 0.825

Bid: 0.80

Ask: 0.85

Change: 0.00 (0.00%)

Spread: 0.05 (6.25%)

Open: 0.825

High: 0.825

Low: 0.825

Prev. Close: 0.825

IQAI Live Price

Last checked at -

Sponsored Content

17 May 2024 08:07

*IQ-AI says Imaging Biometrics software deployed at Insel Gruppe in Switzerland

10 May 2024 08:21

*IQ-AI says US FDA designation is for treatment of atypical teratoid rhabdoid tumor

10 May 2024 08:21

*IQ-AI says US FDA designation is for subsidiary Imaging Biometrics' oral gallium maltolate

10 May 2024 08:20

*IQ-AI says US FDA grants rare pediatric disease designation to lead drug IB-003

2 May 2024 12:49

*IQ-AI gets FDA approval to proceed with expanded access programme for gallium maltolate

1 Mar 2024 08:23

*Free Association Books increases stake in IQ-AI to 8.9% from 3.7% on Friday

22 Feb 2024 08:12

*IQAI says proceeds of GBP300,000 placing to go toward oral gallium maltolate development

22 Feb 2024 08:11

*IQAI launches placing to raise GBP300,000 via issue of 20m shares at 1.5p price

9 Feb 2024 12:53

*IQ-AI says Imaging Biometrics plans to resubmit application by end of next week

9 Feb 2024 12:52

*IQ-AI subsidiary Imaging Biometrics modifying PRD application at FDA's request

2 Feb 2024 08:43

*IQ-AI says IB award is for programme giving brain tumour patients access to pill form of GaM

2 Feb 2024 08:42

*IQ-AI says IB gets award from Musella Foundation For Brain Tumor Research & Information

2 Feb 2024 08:41

*IQ-AI says Imaging Biometrics subsidiary awarded USD100,000 grant for brain tumour programme

10 Jan 2024 07:19

*IQ-AI launches intermediate population cohort expanded program for oral gallium maltolate

19 Dec 2023 14:33

*IQ-AI subsidiary gets US FDA fast track designation for oral gallium maltolate